Blair William & Co./IL has filed a Form 13F-HR with the Securities and Exchange Commission, disclosing its equity portfolio as of the close of business on September 30, 2026. The filing lists the firm's total holdings across a broad range of securities, including common stocks, American Depositary Receipts (ADRs), and exchange-traded funds.
The report identifies Ryan DeVore, Partner and Head of Private Wealth Management, as the authorized signatory for the filing, dated November 10, 2026. The firm’s headquarters is listed as 150 North Riverside Plaza in Chicago, Illinois.
The portfolio includes a diverse mix of large-cap technology and healthcare companies, as well as various exchange-traded funds. Notable positions listed in the filing include Apple Inc., Amazon.com Inc., and Alphabet Inc. Class A and Class C shares. The portfolio also holds significant positions in healthcare entities such as AbbVie Inc., Amgen Inc., and UnitedHealth Group Inc. Additionally, the filing lists positions in financial services companies like American Express Co., JPMorgan Chase & Co., and Visa Inc.
The filing also details holdings in exchange-traded funds, including funds focused on emerging markets, precious metals, and healthcare. Specific ETFs mentioned include the Abrdn Emerging Markets Ex-China Fund, the Abrdn Platinum ETF Trust Physical Platinum Shares, and the Abrdn World Healthcare Fund Class B Shares.
